Bard Loses $2 Million Verdict in Vaginal-Mesh Trial

C.R. Bard Inc. was told by a jury to pay $2 million to a woman who alleged the company hid flaws within some of its vaginal-mesh implants in the first federal trial of claims over the devices.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.